AKT1 and liver cancer: In a mouse model of liver cancer, abnormal expression of exosomal miR-92a-2-5p inhibited the translation of the androgen receptor, leading to alterations in the PHLPP/p-AKT/β-catenin signaling pathway and increased invasiveness of liver cancer cells.